美国国家COVID队列协作中COVID相关急性肾损伤的地理与时间趋势
研究基于美国53个医疗系统的电子健康记录,纳入2020年3月6日至2022年1月6日住院的COVID-19成人患者,评估急性肾损伤(AKI)的发生率、地理分布和时间趋势。AKI发生率在第一期最高(47%),第二期降至37%后趋于稳定;东北、南、西地区在第一期调整后AKI比值高于中西部,随后南部和西部持续最高。
要点
- 住院COVID-19患者中AKI发生率为38%(129,176/336,473)。
- AKI发生率第一期47%、第二期37%,此后相对稳定;南部和西部后续AKI比值持续最高。
核心结论
- 自美国第一波疫情以来,COVID-19相关AKI的发生率和分布发生变化。
研究设计与样本
- 研究获取美国53个医疗系统在国家COVID队列协作中的电子健康记录数据。
- 纳入2020年3月6日至2022年1月6日期间诊断为COVID-19的住院成人。
- AKI通过血清肌酐和诊断代码判定。
- 时间分为16周周期(P1-6),地理区域分为东北、中西部、南部和西部。
- 采用多变量模型分析AKI或死亡的危险因素。
主要发现
- 总队列336,473例中,129,176例(38%)发生AKI。
- AKI发生率P1为47%(23,097/48,947),P2为37%(12,102/32,513),此后相对稳定。
- 与中西部相比,东北、南部和西部在P1的调整后AKI比值更高;随后南部和西部继续具有最高的相对AKI比值。
- 在多变量模型中,由血清肌酐或诊断代码定义的AKI及AKI严重程度与死亡率相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: AKI is associated with mortality in patients hospitalized with coronavirus disease 2019 (COVID-19); however, its incidence, geographic distribution, and temporal trends since the start of the pandemic are understudied. METHODS: Electronic health record data were obtained from 53 health systems in the United States in the National COVID Cohort Collaborative. We selected hospitalized adults diagnosed with COVID-19 between March 6, 2020, and January 6, 2022. AKI was determined with serum creatinine and diagnosis codes. Time was divided into 16-week periods (P1-6) and geographical regions into Northeast, Midwest, South, and West. Multivariable models were used to analyze the risk factors for AKI or mortality. RESULTS: Of a total cohort of 336,473, 129,176 (38%) patients had AKI. Fifty-six thousand three hundred and twenty-two (17%) lacked a diagnosis code but had AKI based on the change in serum creatinine. Similar to patients coded for AKI, these patients had higher mortality compared with those without AKI. The incidence of AKI was highest in P1 (47%; 23,097/48,947), lower in P2 (37%; 12,102/32,513), and relatively stable thereafter. Compared with the Midwest, the Northeast, South, and West had higher adjusted odds of AKI in P1. Subsequently, the South and West regions continued to have the highest relative AKI odds. In multivariable models, AKI defined by either serum creatinine or diagnostic code and the severity of AKI was associated with mortality. CONCLUSIONS: The incidence and distribution of COVID-19-associated AKI changed since the first wave of the pandemic in the United States. PODCAST: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/CJASN/2023_08_08_CJN0000000000000192.mp3.
引用
- Yoo YJ, Wilkins KJ, Alakwaa F, et al. Geographic and Temporal Trends in COVID-Associated Acute Kidney Injury in the National COVID Cohort Collaborative. Clin J Am Soc Nephrol. 2023. PMID: 37131278. doi:10.2215/CJN.0000000000000192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。